Identification of let-7-regulated oncofetal genes

Cancer Research

Volumn 68, Issue 8, 2008, Pages 2587-2591

  Boyerinas, Benjamin ^a   Park, Sun Mi ^a   Shomron, Noam ^b   Hedegaard, Mads M ^c   Vinther, Jeppe ^c   Andersen, Jens S ^d   Feig, Christine ^a,f   Xu, Jinbo ^e   Burge, Christopher B ^b   Peter, Marcus E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e TOYOTA TECHNOLOGICAL INSTITUTE AT CHICAGO   (United States)

^f CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; MESSENGER RNA; MICRORNA; MYC PROTEIN; PROTEIN IMP1; PROTEIN LET7; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CELL GROWTH; CELL MOTILITY; CELL STRAIN HEPG2; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GROWTH INHIBITION; HMGA2 GENE; IMP 1 GENE; LET 7 REGULATED ONCOFETAL GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOFETAL GENE; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; TUMOR CELL; UPREGULATION;

ADENOCARCINOMA; ANIMALS; ANTIGENS, NEOPLASM; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MICE; MICRORNAS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 41649096450     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0264     Document Type: Article

References (18)

1. Abbott AL, Alvarez-Saavedra E, Miska EA, et al. The let-7microRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev Cell 2005;9:403-14.
2. Schulman BR, Esquela-Kerscher A, Slack FJ. Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Dev Dyn 2005;234:1046-54.
3. Shell S, Park SM, Radjabi AR, et al. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A 2007;104:11400-5.
4. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007;315:1576-9.
5. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007;21:1025-30.
6. Park SM, Shell S, Radjabi AR, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007;6:2585-90.
7. Noubissi FK, Elcheva I, Bhatia N, et al. CRD-BP mediates stabilization of βTrCP1 and c-myc mRNA in response to β-catenin signalling. Nature 2006;441:898-901.
8. Nielsen J, Christiansen J, Lykke-Andersen J, et al. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999;19:1262-70.
9. Hansen TV, Hammer NA, Nielsen J, et al. Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol Cell Biol 2004;24:4448-64.
10. Yisraeli JK. VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. Biol Cell 2005;97:87-96.
11. Zhang W, Morris QD, Chang R, et al. The functional landscape of mouse gene expression. J Biol 2004;3:21.
12. Nielsen CB, Shomron N, Sandberg R, et al. Determinants of targeting by endogenous and exogenous microRNA and siRNAs. RNA 2007;13:1894-910.
13. Johnson CD, Esquela-Kerscher A, Stefani G, et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007;67:7713-22.
14. + stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells. J Biol Chem 2005;280:20086-93.
15. Sampson VB, Rong NH, Han J, et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007;67:9762-70.
16. Kato T, Hayama S, Yamabuki T, et al. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer. Clin Cancer Res 2007;13:434-42.
17. Pentimalli F, Dentice M, Fedele M, et al. Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2. Cancer Res 2003;63:7423-7.
18. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995;376:771-4.